Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Gilead: Truvada Will Pass FDA Approval
Seeking Alpha
Mon, 06/11/12 - 01:00 pm
Truvada
Gilead Sciences
FDA
HIV
Quad
Pfizer
Merck
GSK
Bristol-Myers Squibb
Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study
Yahoo/The Fly On The Wall
Sun, 06/10/12 - 11:16 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
diabetes
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Amylin
M&A
Sanofi
AstraZeneca
Merck
Bristol-Myers Squibb
Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Tue, 06/5/12 - 09:34 am
cabozantinib
Exelixis
BMS-936558
MDX-1106
cancer
anti-PD-1 immunotherapy
Bristol-Myers Squibb
Bristol Immune Drug Success In Cancer May Spur Industry Race
Bloomberg
Mon, 06/4/12 - 06:03 pm
Bristol-Myers Squibb
lung cancer
skin cancer
kidney cancer
Celegene, Bristol Drugs No Better Than Cheaper Treatments
Bloomberg
Mon, 06/4/12 - 05:41 pm
Celgene
Bristol-Myers Squibb
Ixempra
Abraxane
breast cancer
Johnson & Johnson, Bristol-Myers' Cancer Drugs Grab Spotlight
Minyanville
Mon, 06/4/12 - 10:55 am
JNJ
Bristol-Myers Squibb
ASCO
Zytiga
anti-PD-1 immunotherapy
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bloomberg
Sun, 06/3/12 - 11:18 am
skin cancer
Bristol-Myers Squibb
BMS-936558
kidney cancer
lung cancer
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Fri, 06/1/12 - 12:30 pm
Bristol-Myers Squibb
Gilead
hepatitis C
Lamberto Andreotti
daclatasvir
GS-7977
Bristol-Myers Might Be Ahead Of Competition In Race To Cure Cancer
Seeking Alpha
Fri, 06/1/12 - 12:12 pm
Bristol-Myers Squibb
cancer
GSK
Merck
Teva Pharmaceuticals
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thu, 05/31/12 - 06:11 pm
Sanofi
liver cancer
GSK
AstraZeneca
Bristol-Myers Squibb
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
AstraZeneca
JNJ
Bristol-Myers Squibb
Eli Lilly
Pfizer
Sanofi
GSK
Buy This Pharma Giant Now For A 30% Return In 2013
Seeking Alpha
Wed, 05/30/12 - 03:04 pm
JNJ
Bayer
Pfizer
Ranbaxy
Bristol-Myers Squibb
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wed, 05/30/12 - 03:01 pm
Amylin
M&A
AstraZeneca
Bristol-Myers Squibb
Pfizer
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
generics
Effient
Plavix
Brilinta
Eli Lilly
bloodthinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Bristol Drug Seen Helping Body Attack Lung Cancer: Health
Bloomberg
Wed, 05/30/12 - 10:21 am
Bristol-Myers Squibb
BMS-936558
lung cancer
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
M&A
Amylin
Sanofi
Merck
Bristol-Myers Squibb
Takeda
AstraZeneca
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
ASCO
Synta
Sunesis
Arqule
Cyclacel
Aveo
Bristol-Myers Squibb
Pages
« first
‹ previous
…
73
74
75
76
77
78
79
80
81
…
next ›
last »